Old Web
English
Sign In
Acemap
>
authorDetail
>
Janet S. Wiegand
Janet S. Wiegand
University of Florida
Apoptosis
Bcl-xL
Cancer research
In vitro
In vivo
2
Papers
16
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Overcoming Gemcitabine Resistance in Pancreatic Cancer Using the BCL-XL Specific Degrader DT2216
2021
Molecular Cancer Therapeutics
Dinesh Thummuri
Sajid Khan
Patrick W. Underwood
Peiyi Zheng
Janet S. Wiegand
Xuan Zhang
Vivekananda Budamagunta
Amin Sobh
Abderrahmane Tagmount
Alex Loguinov
Andrea N. Riner
Ashwin Akki
Elizabeth A. Williamson
Robert Hromas
Chris D. Vulpe
Guangrong Zheng
Jose G. Trevino
Daohong Zhou
Show All
Source
Cite
Save
Citations (1)
DT2216-a Bcl-xL-specific degrader is highly active against Bcl-xL-dependent T cell lymphomas.
2020
Journal of Hematology & Oncology
Yonghan He
Raphael Koch
Vivekananda Budamagunta
Peiyi Zhang
Xuan Zhang
Sajid Khan
Dinesh Thummuri
Yuma T. Ortiz
Xin Zhang
Dongwen Lv
Janet S. Wiegand
Wen Li
Adam C Palmer
Guangrong Zheng
David M. Weinstock
Daohong Zhou
Show All
Source
Cite
Save
Citations (15)
1